English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 46833/50693 (92%)
造訪人次 : 11867073      線上人數 : 705
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CCUR管理 到手機版


    請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/24039


    題名: Identification of SEC61 beta and its autoantibody as biomarkers for colorectal cancer
    作者: Fan, CW (Fan, Chung-Wei)
    Chan, CC (Chan, Chung-Chuan)
    Chen, KT (Chen, Kuei-Tien)
    Twu, J (Twu, Jen)
    Huang, YS (Huang, Ya-Shu)
    Han, CL (Han, Chia-Li)
    Chen, YJ (Chen, Yu-Ju)
    Yu, JS (Yu, Jau-Song)
    Chang, YS (Chang, Yu-Sun)
    Kuo, YB (Kuo, Yung-Bin)
    Chan, EC (Chan, Err-Cheng)
    貢獻者: Dept Chem
    關鍵詞: Autoantibody
    Colorectal cancer
    SEC61 beta
    Serological biomarker
    日期: 2011-05-12
    上傳時間: 2013-01-18 10:58:50 (UTC+8)
    摘要: Background: To identify novel serological biomarkers for human colorectal cancer (CRC). we analyzed CRC tissues using gel-assisted digestion and isobaric tags with related and absolute quantitation (iTRAQ) labeling mass spectrometry (MS). By comparing pairs of tumor tissues and matched normal tissues. we discovered the SEC61 beta with expression changes 3.3-fold and a marginal statistical significance (p=0.052) previously.

    Methods: SEC61 beta expression in CRC tissues was further analyzed by western blotting and immunohistochemistry. We next assessed the putative diagnostic value of the SEC61 beta autoantibody as a serum marker.

    Results: Using western blotting analysis. SEC61 beta expression was increased 1.9-fold in tumor tissues. Immunohistochemical analysis of 64 CRC specimens showed that SEC61 beta was positively detected in 64% of the tumors, but weakly or not detected in > 80% of the adjacent nontumor epithelial cells. Western blot analysis with plasma samples showed that the sensitivity and specificity of the SEC61 beta autoantibody from patients with CRC were 79% and 75%. respectively. Importantly, the results of the SEC61 beta autoantibody for early detection of colorectal cancer revealed a higher sensitivity of 77% than the carcinoembryonic antigen (CEA) assay.

    Conclusions: Measurement of SEC61 beta autoantibody levels may provide an alternative detection indicator for CRC, particularly among early-stage patients. (C) 2011 Elsevier B.V. All rights reserved.
    關聯: CLINICA CHIMICA ACTA Volume: 412 Issue: 11-12 Pages: 887-893
    顯示於類別:[化學系所] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML319檢視/開啟


    在CCUR中所有的資料項目都受到原著作權保護.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋